Antimicrobial susceptibility of heucobacter pylori isolated from gastric biopsies in dyspeptic patients

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 39, Issue 6, 2008, Pages 1102-1109

  Kulsuntiwong, Panthong ^a   Chomvarin, Chariya ^a   Chaicumpar, Kunyaluk ^a   Namwat, Wises ^a   Kaewkes, Wanlop ^a   Mairiang, Pisaln ^a   Sangchan, Apichat ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DISK DIFFUSION; DRUG EFFECT; DYSPEPSIA; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; STOMACH ANTRUM; THAILAND;

ANTI-BACTERIAL AGENTS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSPEPSIA; HELICOBACTER PYLORI; HUMANS; PYLORIC ANTRUM; THAILAND;

EID: 56849094266     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Al-Qurashi AR, El-Morsy F, Al-Quorain AA. Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia. Int J Antimicrob Agents 2001; 17:233-6.
2. Alarcon T, Domingo D, Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents 1999; 12: 19-26.
3. Arents NL, Smeets LC, van Zwet AA, et al. Implications of the simultaneous presence of metronidazole-susceptible and -resistant Helicobacter pylori colonies within a single biopsy specimen. Eur J Clin Microbiol Infect Dis 2001; 20: 418-20.
4. Boyanova L, Mentis A, Gubina M, et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect 2002; 8: 388-96.
5. Boyanova L, Stancheva I, Spassova Z, et al. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. J Med Microbiol 2000; 49: 415-8.
6. Cabrita J, Oleastro M, Matos R, et al. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999). J Antimicrob Chemother 2000; 46: 1029-31.
7. Chaves S, Gadanho M, Tenreiro R, et al. Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test. J Clin Microbiol 1999; 37: 1628-31.
8. Debets-Ossenkopp YJ, Reyes G, Mulder J, et al. Characteristics of clinical Helicobacter pylori strains from Ecuador. J Antimicrob Chemother 2003; 51: 141-5.
9. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10: 720-41.
10. Eltahawy AT. Prevalence of primary Helicobacter pylori resistance to several antimicrobials in a Saudi Teaching Hospital. Med Princ Pract 2002; 11: 65-8.
11. Eun CS, Han DS, Park JY, et al. Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases. J Gastroenterol 2003; 38: 436-41.
12. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 8-13.
13. Fukazawa K, Seki M, Satoh K, et al. [Antimicrobial resistance testing of H. pylori epsilometer test and disk diffusion test]. Nippon Rinsho 1999; 57: 76-80.
14. Glupczynski Y. Antimicrobial resistance in Helicobacter pylori: a global overview. Acta Gastroenterol Belg 1998; 61: 357-66.
15. Heep M, Kist M, Strobel S, et al. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis 2000; 19: 538-41.
16. Hoffman JS. Pharmacological therapy of Helicobacter pylori infection. Semin Gastrointest Dis 1997; 8: 156-63.
17. Hoshiya S, Watanabe K, Tokunaga K, et al. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. J Gastroenterol 2000; 35: 10-4.
18. Hua J, Ng HC, Yeoh KG, et al. Predominance of a single strain of Helicobacter pylori in gastric antrum. Helicobacter 1999; 4: 28-32.
19. Hua JS, Bow H, Zheng PY, et al. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in Singapore. World J Gastroenterol 2000; 6: 119-121.
20. Kim JJ, Kim JG, Kwon DH. Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 2003; 8: 202-6.
21. Koletzko S, Richy F, Bontems P, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 2006; 55: 1711-6.
22. Kwon DH, Kim JJ, Lee M, et al. Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 2000; 44: 3203-5.
23. Lacy BE, Rosemore J. Helicobacter pylori: ulcers and more: the beginning of an era. J Nutr 2001; 131:S2789-93.
24. Lang L, Garcia F. Comparison of E-test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica. Int J Antimicrob Agents 2004; 24: 572-7.
25. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11 (suppl 1): 43-53.
26. Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998; 115: 1278-82.
27. Megraud F. Evolution of Helicobacter pylori research as observed through the workshops of the European Helicobacter Study Group. Helicobacter 2007; 12 (suppl 2): 1-5.
28. Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007; 20: 280-322.
29. Mentis AF, Roma E, Pangalis A, et al. Susceptibilities of Helicobacter pylori strains isolated from children with gastritis to selected antibiotics. J Antimicrob Chemother 1999; 44: 720-2.
30. Mishra KK, Srivastava S, Garg A, et al. Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods. Curr Microbiol 2006; 53: 329-34.
31. Mukhopadhyay AK, Kersulyte D, Jeong JY, et al. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol 2000; 182: 3219-27.
32. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6.
33. Osato MS, Reddy R, Graham DY. Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. Int J Antimicrob Agents 1999; 12: 341-7.
34. Piccolomini R, Di Bonaventura G, Catamo G, et al. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol 1997; 35: 1842-6.
35. Quintana-Guzman EM, Arias-Echandi ML, Salas-Chaves P, et al. Helicobacter pylori: susceptibility to amoxicillin, erythromycin, tetracycline, ciprofloxacin, nitrofurantoin and metronidazole in Costa Rica. Rev Biomed 1998; 9: 92-6.
36. Rafeey M, Ghotaslou R, Nikvash S, et al. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother 2007; 13:291-5.
37. Sack RB, Gyr K. Helicobacter pylori infections in the developing world. Summary of a workshop organized at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) from February 2 to 4, 1993. J Diarrhoeal Dis Res 1994; 12: 144-5.
38. Samra Z, Shmuely H, Niv Y, et al. Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J Antimicrob Chemother 2002; 49: 1023-6.
39. Sharara Al, Chedid M, Araj GF, et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin and tetracycline in Lebanon. Int J Antimicrob Agents 2002; 19: 155-8.
40. Siavoshi F, Safari F, Doratotaj D, et al. Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children. Arch Iran Med 2006;9:308-14.
41. Street ME, Caruana P, Caffarelli C, et al. Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome. Arch Dis Child 2001; 84:419-22.
42. Taneike I, Goshi S, Tamura Y, et al. Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parents. Helicobacter 2002; 7: 297-305.
43. Tangmankongworakoon N, Mahachai V, Thong-Ngam D, et al. Pattern of drug resistant Helicobacter pylori in dyspeptic patients in Thailand. J Med Assoc Thai 2003; 86 (suppl 2): S439-44.
44. Wang WH, Wong BC, Mukhopadhyay AK, et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment Pharmacol Ther 2000; 14: 901-10.
45. Wongkusoltham P, Vilaichone RK, Kullavanijaya P, et al. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease. J Med Assoc Thai 2001; 84 (suppl 1): S474-80.
46. Xia H, Keane CT, Beattie S, et al. Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 1994; 38: 2357-61.
47. Yakoob J, Fan X, Hu G, et al. Antibiotic susceptibility of Helicobacter pylori in the Chinese population. J Gastroenterol Hepatol 2001; 16: 981-5.
48. Yakoob J, Hu G, Fan X, et al. Helicobacter pylori detection in Chinese subjects: a comparison of two common DNA fingerprinting methods. Br J Biomed Sci 2001; 58: 239-43.
49. Yang YJ, Yang JC, Jeng YM, et al. Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children. Pediatr Infect Dis J 2001; 20: 662-6.